Market Analysis of Diabetic Products

Diabetes care market encompasses of technologies, devices and therapeutics in relative to diabetes. There has been a substantial increase in the amount of diabetes cases internationally over the last few years. Currently, about millions of people are in misery because of obesity, which is a key reason for increase of diabetes in people. Key Players profiled in the report include Glaxosmithkline, Novo Nordisk, Roche, Medtronicand etc. Novo Nordisk is a leading global provider of diabetes products. The company also has a headship spot in hemostasis management, growth hormone therapy and hormone replacement therapy. The company progresses, manufactures and markets its medical devices and technologies to hospitals, doctors, researchers, scientists and patients in approximately 160 countries.

  • Hormone replacement therapy
  • Blood glucose monitoring system
  • Smart insulin
  • Timesulin
  • Insulin Powder

Related Conference of Market Analysis of Diabetic Products

October 30-November 01, 2017

10th International Conference on Endocrinology

Chicago, Illinois, USA
December 04-05, 2017

25th Global Diabetes Summit and Medicare Expo

Dubai, UAE
March 8-9, 2018

17th Global Diabetes Conference & Nursing Care

| Paris, France
May 23-24, 2018

11th Diabetologists Conference

New York, USA
June 20-21, 2018

27th European Diabetes Congress

| Rome, Italy
July 16-17, 2018 Sydney, Australia

20th Asia Pacific Diabetes Conference

August 20-21, 2018

28th World Congress on Diabetes, Obesity & Heart

Tokyo, Japan
September 03-04, 2018

2nd International Conference on Thyroid and Pregnancy

Auckland, New Zealand
September 3-4, 2018

11th World Congress on Endocrinology and Metabolic Disorders

Auckland, New Zealand
November 26-27, 2018

13th European Diabetes and Endocrinology Congress

Dublin, Ireland

Market Analysis of Diabetic Products Conference Speakers

Recommended Sessions

Related Journals

Are you interested in